Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.280
-0.010 (-0.78%)
Jul 15, 2026, 10:17 AM EDT - Market open
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $92.54 million as of July 15, 2026. Its market cap has decreased by -9.84% in one year.
Market Cap
92.54M
Enterprise Value
49.81M
1-Year Change
-9.84%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $92.54M, a decrease of -81.08%. That is a compound annual growth rate of -27.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 92.54M | 5.56% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 104.11M |
| Verrica Pharmaceuticals | 101.70M |
| ImmuCell | 100.24M |
| PolyPid | 96.64M |
| Alterity Therapeutics | 95.83M |
| Inovio Pharmaceuticals | 95.44M |
| Cardiff Oncology | 92.30M |
| LeonaBio | 91.68M |